We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Analytical Trick Improves Efficiency of Protein Analysis

By LabMedica International staff writers
Posted on 03 Mar 2013
Print article
Researchers have developed a new, multisample technique to accelerate protein identification and quantification by mass spectrometry.

Mass spectrometry (MS) is often used to examine protein variations. Chemists have recently begun to double-up with two different samples in a single run, e.g., to compare normal to diseased tissue to examine how the proteins change. Now, researchers at the University of Wisconsin-Madison (WISC; Madison, WI; USA) led by Joshua Coon, professor of chemistry and biomolecular chemistry, have built on this by developing a technique, termed “neutron-encoding,” with potential to multiplex 20 samples at once.

In the current study, the team investigated mouse tissue for potential biochemical pathways underlying the correlation between caloric restriction and extended lifespan previously observed in many animals. "Some of these mice have lost a certain gene related to metabolism, so we are comparing four types of tissue all at once. We can look at the brain, liver, or heart, and ask how does the abundance of proteins vary?" said first author and graduate student Alexander Hebert.

The team has performed six simultaneous analyses using the new technique; it could do batches of 20. Key to the existing, original doubling-up technique was synthetically inserting stable isotope tags into the amino acids used in metabolic labeling of proteins. In preparing two samples, one sample would receive an amino acid containing common isotopes, the other containing heavier isotopes. The result—chemically identical proteins with slightly different masses easily identified by MS.

The new report describes the use of amino acids built from a broader range of isotopes that would be expected to have identical mass, but do not since part of their mass has been converted to energy required to hold the atomic nuclei together. Without this energy, the positively charged proteins would repel each other and the atomic nucleus would be destroyed. The tiny loss of mass due to this conversion to binding energy can be detected in the new, ultra-precise mass spectrometers. The mass difference in the new technique is more than 1,000 times below the mass differences in the existing doubled-up technique, but it is enough to quantify and identify proteins from at least 6, and theoretically, 20 samples at once.

Prof. Coon added, "We could look for protein differences in cells from 100 different tumors. The proteins might reveal that you are dealing with 5 or 10 distinct syndromes in this seemingly identical cancer, which could suggest treatments that are more tailored to the individual. If you compare proteins in normal versus tumor tissue, you might find a certain protein at uncommonly high concentrations, or [that] was modified in certain ways. You might identify a protein that would help diagnose this cancer sooner [or] a protein that is so vital to the cancer that it would make an ideal target for a new drug."

The new procedure was described advanced online February 24, 2013, in the journal Nature Methods.

Related Links:
University of Wisconsin-Madison
Wisconsin Institute for Discovery


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.